4//SEC Filing
JACOB LEONARD S 4
Accession 0001209191-21-012544
CIK 0001016169other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 7:08 PM ET
Size
9.0 KB
Accession
0001209191-21-012544
Insider Transaction Report
Form 4
JACOB LEONARD S
Director
Transactions
- Exercise/Conversion
Common Stock
2021-02-18$2.24/sh+15,321$34,319→ 268,363 total - Sale
Common Stock
2021-02-18$5.05/sh−15,321$77,371→ 253,042 total - Exercise/Conversion
Stock Option (right to buy)
2021-02-18−15,321→ 0 totalExercise: $2.24Exp: 2021-09-08→ Common Stock (15,321 underlying)
Footnotes (2)
- [F1]The stock option exercise and sale of common stock reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The options vested and become exercisable one year from the grant date of September 9, 2011.
Documents
Issuer
ANTARES PHARMA, INC.
CIK 0001016169
Entity typeother
IncorporatedNY
Related Parties
1- filerCIK 0001049713
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 7:08 PM ET
- Size
- 9.0 KB